Get started
Inovio Pharmaceuticals, Inc.
Long

$INO Inovio Pharma a Ricky hold into earnings

826
Stock is sitting at a very critical level as earnings approach.
A drop below $19.00 could see a sharp drop to the Fibonacci Golden pocket at $16.00 or to the POC (redline) @ $13.87
Risky hold into earnings

Inovio Pharmaceuticals, Inc. is a late-stage biotechnology company. It engages in the discovery, development, and commercialization of DNA-based immunotherapies and vaccines. The firm's drug candidates include SynCon immunotherapies which helps break the immune system’s tolerance of cancerous cells; and CELLECTRA delivery system which facilitates optimized cellular uptake of the SynCon immunotherapies. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.
RedHotStocks
Also on:
Chart PatternsTechnical IndicatorsTrend Analysis

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Chart PatternsTechnical IndicatorsTrend Analysis
RedHotStocks
Also on:

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.